94 related articles for article (PubMed ID: 4267067)
21. [Histological and ultrastructural studies of the mucosa of the large intestine in patients with ulcerative colitis].
Wierzchowski W; Kirchmayer S; Dabros W; Bogdał J; Mach T; Goszcz A; Stachura J
Patol Pol; 1984; 35(4):423-34. PubMed ID: 6535949
[No Abstract] [Full Text] [Related]
22. [Significance of morphologic and functional changes in the small intestine in diagnosing the severity of the course of chronic entercolitis].
Larchenko NT; Odinokova VA
Arkh Patol; 1970; 32(9):25-9. PubMed ID: 5514503
[No Abstract] [Full Text] [Related]
23. Altered intestinal permeability is predictive of early relapse in children with steroid-responsive ulcerative colitis.
Miele E; Pascarella F; Quaglietta L; Giannetti E; Greco L; Troncone R; Staiano A
Aliment Pharmacol Ther; 2007 Apr; 25(8):933-9. PubMed ID: 17402997
[TBL] [Abstract][Full Text] [Related]
24. [Features of inflammation of the mucosa of the large intestine in nonspecific ulcerative colitis and Crohn's disease].
Novikova AV; Shcherbakov IT; Ol'shanskiĭ IaO; Iurkov MM; Levitan MKh
Arkh Patol; 1982; 44(9):31-9. PubMed ID: 6756359
[TBL] [Abstract][Full Text] [Related]
25. Granulocytapheresis in the treatment of patients with active ulcerative colitis.
Bresci G
Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):639-43. PubMed ID: 19072341
[TBL] [Abstract][Full Text] [Related]
26. [Crohn disease and ulcerative colitis - current status: pathologico-anatomic aspects].
Haferkamp O
Chirurg; 1981 Dec; 52(12):737-43. PubMed ID: 6459218
[No Abstract] [Full Text] [Related]
27. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
28. Atypical mitoses in colectomy specimens from patients with long standing ulcerative colitis.
Rubio CA; Befrits R
Anticancer Res; 1997; 17(4A):2721-6. PubMed ID: 9252704
[TBL] [Abstract][Full Text] [Related]
29. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis.
Renzi D; Mantellini P; Calabrò A; Panerai C; Amorosi A; Paladini I; Salvadori G; Garcea MR; Surrenti C
Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):62-70. PubMed ID: 9615269
[TBL] [Abstract][Full Text] [Related]
30. A quantitative method of estimating inflammation in the rectal mucosa. IV. Ulcerative colitis in remission.
Rubio CA; Johansson C; Uribe A; Kock Y
Scand J Gastroenterol; 1984 Jun; 19(4):525-30. PubMed ID: 6463576
[TBL] [Abstract][Full Text] [Related]
31. [Experiences with the rectal azulfidine therapy].
Hanke P; Schulz U
Z Gesamte Inn Med; 1971 Nov; 26(21):Suppl:292-3. PubMed ID: 4402345
[No Abstract] [Full Text] [Related]
32. A unified concept of the vascular pathogenesis of enterocolitis of varied etiology. A pathophysiologic analysis.
Allen AC
Am J Gastroenterol; 1971 Apr; 55(4):347-78. PubMed ID: 5565842
[No Abstract] [Full Text] [Related]
33. Bactericidal/permeability-increasing protein in colonic mucosa in ulcerative colitis.
Haapamäki MM; Häggblom JO; Grönroos JM; Pekkala E; Alanen K; Nevalainen TJ
Hepatogastroenterology; 1999; 46(28):2273-7. PubMed ID: 10521980
[TBL] [Abstract][Full Text] [Related]
34. [On the histologic, endoscopic and clinical aspects during idiopathic ulcerohemorrhagic colitis].
Dodero M; Celle G; Michetti P; Ciravegna G; Neumaier F
Minerva Gastroenterol; 1970; 16(3):120-30. PubMed ID: 5312708
[No Abstract] [Full Text] [Related]
35. Expressing the differences between Crohn disease and ulcerative colitis.
Wijmenga C
PLoS Med; 2005 Aug; 2(8):e230; quiz e304. PubMed ID: 16120009
[TBL] [Abstract][Full Text] [Related]
36. Proceedings: The proximal jejunal mucosa in colonic Crohn's disease and ulcerative colitis.
Ferguson R; Allan RN; Cooke WT
Gut; 1974 Oct; 15(10):839. PubMed ID: 4434970
[No Abstract] [Full Text] [Related]
37. [Activity of small intestine alkaline phosphatase in the feces in chronic intestinal diseases].
Lehmann FG; Cramer P; Hillert U
Z Gastroenterol; 1980 Apr; 18(4):208-15. PubMed ID: 7424074
[TBL] [Abstract][Full Text] [Related]
38. [Immunomorphological characteristics of mucosal and endocrine cells of the colon in patients with chronic ulcerative colitis].
Rybakova MG; Botina AV; Solov'eva OI
Arkh Patol; 2005; 67(2):30-3. PubMed ID: 15938117
[TBL] [Abstract][Full Text] [Related]
39. Histopathology of chronic ulcerative colitis.
Sanchez-Casis G
Can J Surg; 1974 Nov; 17(6):418-9. PubMed ID: 4429916
[No Abstract] [Full Text] [Related]
40. Vascular changes in ulcerative colitis and Leśniowski-Crohn's disease.
Zurawski J; Woźniak A; Salwa-Zurawska W; Kaczmarek E; Majewski P
Pol J Pathol; 2007; 58(1):13-21. PubMed ID: 17585538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
